StudyKIK Company Profile

Background

Overview

Founded in 2014, StudyKIK is a full-service patient recruitment and retention technology company headquartered in Santa Monica, California. The company specializes in leveraging technology, social media, and indication-specific expertise to connect patients with clinical trials, thereby ensuring that study timelines and sponsor budgets are met. Since its inception, StudyKIK has reached over 6 million patients and connected more than 3.1 million patients to various studies.

Mission and Vision

StudyKIK's mission is to streamline the clinical trial process by enhancing patient recruitment and retention through innovative technological solutions. The company envisions a future where clinical trials are more accessible to diverse patient populations, thereby accelerating medical advancements and improving global health outcomes.

Industry Significance

Operating within the research services industry, StudyKIK plays a pivotal role in addressing the challenges associated with patient enrollment and retention in clinical trials. By providing tailored recruitment and technology solutions for patients, research sites, Contract Research Organizations (CROs), and sponsors, StudyKIK contributes significantly to the efficiency and success of clinical research endeavors.

Key Strategic Focus

Core Objectives

Patient Recruitment and Retention: Utilizing advanced technologies and social media platforms to identify and engage potential clinical trial participants.

Technology Integration: Developing and implementing customized applications to assist with patient retention once participants are randomized.

Global Reach: Expanding services to connect a diverse and international patient population with appropriate clinical trials.

Areas of Specialization

Clinical Trial Enrollment Support: Facilitating the matching of patients to suitable clinical trials based on specific medical conditions and study requirements.

Healthcare Marketing: Employing targeted marketing strategies to raise awareness about clinical trials and encourage participation.

Key Technologies Utilized

Social Media Platforms: Leveraging platforms like Facebook and Twitter to reach potential participants.

Customized Mobile Applications: Developing apps that provide study information, reminders, and support to enrolled participants.

Data Analytics: Utilizing analytics to optimize recruitment strategies and improve patient engagement.

Primary Markets Targeted

Pharmaceutical Companies: Assisting sponsors in meeting recruitment goals for various clinical trials.

Contract Research Organizations (CROs): Providing CROs with tools and services to enhance their recruitment capabilities.

Research Sites: Supporting individual research sites in managing and retaining study participants.

Financials and Funding

Revenue

Estimates of StudyKIK's annual revenue vary:

Approximately $12 million.

Approximately $43.7 million.

Funding History

Specific details regarding StudyKIK's funding rounds are not publicly disclosed. However, the company has demonstrated significant growth and expansion since its founding.

Acquisition

In September 2021, StudyKIK was acquired by Syneos Health, a leading biopharmaceutical solutions organization. This acquisition aimed to enhance Syneos Health's patient recruitment and retention capabilities by integrating StudyKIK's innovative technologies and patient-centric approach.

Pipeline Development

As a service-oriented company, StudyKIK does not have a traditional product pipeline. Instead, its focus is on continuously developing and refining its technological platforms and services to better serve clients in the clinical research industry.

Technological Platform and Innovation

Proprietary Technologies

Patient Recruitment Platform: A comprehensive system that utilizes social media and digital marketing to identify and engage potential clinical trial participants.

Retention Applications: Customized mobile apps designed to enhance patient engagement and retention throughout the duration of a clinical trial.

Significant Scientific Methods

Data Analytics: Employing advanced analytics to optimize recruitment strategies and improve patient engagement.

Machine Learning Algorithms: Utilizing machine learning to predict patient behavior and tailor recruitment efforts accordingly.

Leadership Team

Matt Miller: Co-Founder and Chief Executive Officer.

Brian Kay: Chief Operating Officer.

Sam Haiden: Chief Strategy Officer.

Stace Baal: Chief Technology Officer.

Kevin Vass: Chief Financial Officer.

Kimberly Odle: Vice President of Project Management.

These leaders bring a wealth of experience in clinical research, technology development, and business strategy, driving StudyKIK's mission to innovate patient recruitment and retention in clinical trials.

Leadership Changes

In August 2018, Alex Lithwick joined StudyKIK as Chief Financial Officer, bringing extensive experience in financial management to the company.

Competitor Profile

Market Insights and Dynamics

The clinical trial recruitment industry is experiencing significant growth, driven by the increasing complexity of clinical trials and the need for efficient patient enrollment strategies. Technological advancements and the integration of digital platforms are transforming traditional recruitment methods, emphasizing the importance of patient-centric approaches.

Competitor Analysis

StudyKIK operates in a competitive landscape with several key players:

Trialbee: Specializes in patient recruitment and engagement solutions, utilizing data-driven strategies to optimize clinical trial enrollment.

Antidote: Focuses on connecting patients with clinical trials through an extensive online platform, aiming to accelerate medical research.

Clinerion: Offers real-time patient data solutions to improve the efficiency of clinical trials, emphasizing data integration and analytics.

These competitors, like StudyKIK, leverage technology to enhance patient recruitment and retention, each bringing unique methodologies and platforms to the industry.

Strategic Collaborations and Partnerships

StudyKIK's acquisition by Syneos Health in 2021 represents a significant strategic collaboration, combining StudyKIK's innovative recruitment technologies with Syneos Health's comprehensive biopharmaceutical solutions. This partnership aims to enhance patient engagement and streamline the clinical trial process.

Operational Insights

StudyKIK's strategic considerations include:

Technological Differentiation: Continuously enhancing its proprietary platforms to offer superior patient recruitment and retention services.

Market Positioning: Leveraging its acquisition by Syneos Health to expand its market reach and service offerings.

Competitive Advantages: Utilizing a patient-centric approach and advanced data analytics to differentiate itself from competitors.

Strategic Opportunities and Future Directions

Looking ahead, StudyKIK is poised to:

Expand Global Reach: Increase its presence in international markets to connect a more diverse patient population with clinical trials.

Enhance Technological Capabilities: Invest in emerging technologies such as artificial intelligence and machine learning to further optimize recruitment strategies.

Strengthen Industry Partnerships: Develop collaborations with pharmaceutical companies, CROs, and research institutions to enhance service offerings and drive innovation in clinical trial recruitment and retention.